Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
DOI: 10.1039/C8RA90011F
(Correction)
RSC Adv., 2018, 8, 8007-8009
Correction: Menaquinone biosynthesis inhibition: a review of advancements toward a new antibiotic mechanism
M. Boerschab,
S. Rudrawarabc,
G. Grantabc and
M. Zunk*abc
aSchool of Pharmacy and Pharmacology, Griffith University, Gold Coast, Queensland 4222, Australia. E-mail: m.zunk@griffith.edu.au
bQuality Use of Medicines Network, Griffith University, Gold Coast, Queensland 4222, Australia
cMenzies Health Institute Queensland, Griffith University, Gold Coast, QLD 4222, Australia
Received
31st January 2018
, Accepted 31st January 2018
First published on 20th February 2018
Abstract
Correction for ‘Menaquinone biosynthesis inhibition: a review of advancements toward a new antibiotic mechanism’ by M. Boersch et al., RSC Adv., 2018, 8, 5099–5105.
The authors regret that there was an error in Fig. 4 in the original manuscript, because the headings for the MIC data were not displayed. The correct figure which includes the headings is shown below. Reference 1 in this correction article refers to reference 37 in the original article.
 | ||
| Fig. 4 The five classes of compounds discovered by Debnath et al. with minimum inhibitory concentrations for both the microplate alamar blue assay, and the low-oxygen recovery assay using M. tuberculosis. The MIC values shown are of the best example discovered of each class.1 | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
References
- J. Debnath, S. Siricilla, B. Wan, D. C. Crick, A. J. Lenaerts and S. G. Franzblau, et al., Discovery of selective menaquinone biosynthesis inhibitors against Mycobacterium tuberculosis, J Med Chem., 2012, 55(8), 3739–3755 CrossRef CAS PubMed.
| This journal is © The Royal Society of Chemistry 2018 |